Antiparkinsonian Medication Reconciliation as a Strategy to Improve Safety by Preventing Medication Errors
Movement Disorders Clinical Practice · 2023-07 · 10 (7) · 1090-1098
DOI: 10.1002/mdc3.13789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 23.05.2023. Verfasst von Adrián Viudez-Martínez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department Instituto Investigación Biomédica y Sanitaria de Alicante (ISABIAL) Hospital General Universitario Dr. Balmis Alicante Spain. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Background
About 70% of neurologists report that PD patients do not get their medication properly when hospitalized, and 33% are prescribed contraindicated drugs.
Objectives
To execute medication reconciliation (MedRec) focused on antiparkinsonian drugs to identify, characterize and, eventually, prevent medication errors, thus promoting therapeutic quality and safety in daily practice.
Methods
An interventional, single‐center, 1 year, prospective study. All the patients who were hospitalized and had, at least, one active prescription containing an antiparkinsonian drug at hospital admission were included. MedRec was performed by following a three‐phased check: inpatient electronic prescription validation after assessing the outpatient medication schedule, review of the latest clinical report emitted by the Neurology Department/General Practitioner, and pharmacist‐driven interview of the patient and/or caregiver to confirm the information regarding medication gathered.
Results
A total of 171 admission episodes from 132 patients were registered (February 1, 2021, and January 31, 2022). Of 224 prescription lines involving antiparkinsonian drugs, 179 contained, at least, one medication error (59.8%). Commission errors (91.62%) were more frequent than omitted drugs (8.38%). The most common medication errors were related to timing (41.90%), frequency (21.23%), and dosing (19.55%). The implementation of this program prevented the erroneous administration of 2716 antiparkinsonian doses, 60% of the total number of doses prescribed. Interestingly, a significant relationship between the number of medication errors and having levodopa prescribed was evidenced ( P < 0.05). A contraindicated drug was prescribed in almost one‐third of the episodes (29.82%).
Conclusions
Clinical pharmacists' implementation of an antiparkinsonians reconciliation program sharply reduced medication errors and prescription of contraindicated drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacy Department Instituto Investigación Biomédica y Sanitaria de Alicante (ISABIAL) Hospital General Universitario Dr. Balmis Alicante Spain.
ORCID-Profile: Adrián Viudez-Martínez, Ana Ramírez-López, Javier López-Nieto, Eduardo Climent-Grana, Gerónima Riera
Zitieren
APA
Viudez-Martínez, A., Ramírez-López, A., López-Nieto, J., Climent-Grana, E., & Riera, G. (2023). Antiparkinsonian Medication Reconciliation as a Strategy to Improve Safety by Preventing Medication Errors. Movement Disorders Clinical Practice, 10(7), 1090-1098. https://doi.org/10.1002/mdc3.13789
Vancouver
Viudez-Martínez A, Ramírez-López A, López-Nieto J, Climent-Grana E, Riera G. Antiparkinsonian Medication Reconciliation as a Strategy to Improve Safety by Preventing Medication Errors. Movement Disorders Clinical Practice. 2023;10(7):1090-1098. doi:10.1002/mdc3.13789
BibTeX
@article{ViudezMartnez2023,
author = {Viudez-Martínez, Adrián and Ramírez-López, Ana and López-Nieto, Javier and Climent-Grana, Eduardo and Riera, Gerónima},
title = {Antiparkinsonian Medication Reconciliation as a Strategy to Improve Safety by Preventing Medication Errors},
journal = {Movement Disorders Clinical Practice},
year = {2023},
volume = {10},
number = {7},
pages = {1090--1098},
doi = {10.1002/mdc3.13789}
}
EUVIMED